Crossmark

Application of machine learning to large in-vitro databases to identify cancer cell characteristics: telomerase reverse transcriptase (TERT) expression

Crossref DOI link: https://doi.org/10.1038/s41388-021-01894-3

Published Online: 2021-06-16

Published Print: 2021-08-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sherman, Jeff https://orcid.org/0000-0003-1377-0357
Verstandig, Grant

Brumer, Yisroel https://orcid.org/0000-0002-7046-0198
License Information

Text and Data Mining valid from 2021-06-16

Version of Record valid from 2021-06-16
More Information

Article History

Received: 15 March 2021

Revised: 21 May 2021

Accepted: 4 June 2021

First Online: 16 June 2021

Competing interests

: The authors have roles at Red Cell Partners and Zephyr AI that involve the application of AI to cancer drug discovery. The authors report no known financial interest in HDAC1 or complex I inhibitors.

Document is current

Any future updates will be listed below